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Abstract The glycolytic enzyme phosphoglycerate mutase
exists in two evolutionarily unrelated forms. Vertebrates have
only the 2,3-bisphosphoglycerate-dependent enzyme (dPGM),
whilst higher plants have only the cofactor-independent enzyme
(iPGM). Certain eubacteria possess genes encoding both
enzymes, and their respective metabolic roles and activities are
unclear. We have over-expressed, purified and characterised the
two PGMs of Escherichia coli. Both are expressed at high levels,
but dPGM has a 10-fold higher specific activity than iPGM.
Differential inhibition by vanadate was observed. The presence of
an integral manganese ion in iPGM was confirmed by EPR
spectroscopy.
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1. Introduction
Phosphoglycerate mutases (EC 5.4.2.1) catalyse the inter-
conversion of 2-phosphoglycerate (2-PGA) and 3-phosphogly-
cerate (3-PGA) in the Embden-Meyerho¡ pathway. Two ap-
parently evolutionarily unrelated enzymes with phospho-
glycerate mutase activity have been characterised. One enzyme
(dPGM) requires the cofactor 2,3-bisphosphoglycerate (2,3-
BPGA) for activity, whilst the other (iPGM) does not. The
recent advances in whole-genome sequencing have provided
new data on the distribution of these two enzymes over a wide
range of organisms [1]. Vertebrates, budding yeast, and vari-
ous eubacterial species have only dPGM whilst nematodes,
archaea, higher plants and various other eubacteria possess
only iPGM. In addition, a small number of eubacteria appear
to encode both enzymes (Fig. 1). This complex distribution
could have arisen if both genes existed early in evolution,
followed by selective loss of one or other in di¡erent phyla.
The absence of iPGM in vertebrates, including humans,
makes the enzyme a potential drug target in those organisms
containing the gene, which includes many species of patho-
genic bacteria, nematodes and other parasites.
dPGM belongs to an enzyme family whose members in-
clude bisphosphoglycerate synthase, fructose 2,6-bisphospha-
tase, pyrophosphatase and acid phosphatase [2]. Sequence
motifs suggest that all of these enzymes have a conserved
histidine at the active site that becomes reversibly phosphory-
lated during the catalytic cycle. The crystal structure of
dPGM from Saccharomyces cerevisiae has been solved at 2.1
Aî resolution [3,4], and spectral and kinetic studies, combined
with site-directed mutagenesis, have served to de¢ne many of
the properties of the cofactor-dependent enzyme [3,5^8].
Nevertheless certain fundamental details of the catalytic
mechanism, such as the suggested requirement for reorienta-
tion of intermediates during catalysis [3], remain unclear.
iPGM is a member of the alkaline phosphatase superfamily
[1,9], which is composed of a wide range of enzymes catalys-
ing the transfer of phospho- or sulphate groups. Other mem-
bers include phosphopentomutase, phosphoglycerol transfer-
ase, Ca2-dependent ATPase and a number of sulphatases [1].
These enzymes share a very limited degree of sequence iden-
tity that may re£ect conservation of certain active site and
metal binding residues. Details of the catalytic mechanism
of iPGM are not well understood, though a phospho-enzyme
intermediate has been postulated [10] and essential histidine
residues have been identi¢ed [11].
Given the intriguing distribution of phosphoglycerate mu-
tases, with both enzymes expressed in some bacterial species,
and the potential of iPGM as a drug target, we chose to
characterise both dPGM and iPGM from Escherichia coli.
The enzymes were over-expressed and puri¢ed to homogene-
ity. Steady-state kinetic parameters were determined, allowing
comparison of the speci¢c activities of the two enzymes. Dif-
ferential inhibition by vanadate allowed the quantitation of
both proteins as a function of growth phase in E. coli, and the
presence of manganese in E. coli iPGM was con¢rmed by
EPR spectroscopy.
2. Materials and methods
2.1. Cloning the phosphoglycerate mutase genes
The gene for cofactor-dependent phosphoglycerate mutase (gpmA,
accession number P31217) was a kind gift from Dr W.N. Hunter, and
was supplied as an insert in the vector pET3a, allowing over-expres-
sion of the native protein in E. coli strain BL21 (DE3). The gene for
cofactor-independent phosphoglycerate mutase, pgmI (accession num-
ber P37689), was ampli¢ed by PCR using Vent exo+ proof-reading
polymerase (NEB), from E. coli strain DH5K, using oligonucleotide
primers:
5P primer: 5P- CGTCGGATCCCATATGGCCATGGCGGTTTCTAAAAAA-
CCTATGGTACTGGTGATTC
3P primer: 5P- GGCAGGATCCGTCGACTTATTCCACGATGAACAGCGG-
CTTACCAG
The oligonucleotides introduced several restriction sites at either end
of the ampli¢ed gene to facilitate subcloning. Ampli¢ed pgmI was
subcloned into the BamHI site of vector pUC119 (Clontech), creating
the plasmid pUC119-pgmI. The pgmI gene was sequenced completely
to ensure that no errors had been introduced in the ampli¢cation
process; the sequence was identical to that published. The pgmI
gene was subcloned from pUC119-pgmI into the BamHI and SalI
sites of the expression vector pET15b (Novagen), allowing expression
of iPGM with a six-histidine tag at the N-terminus, which resulted in
the 22 amino acid extension MGSSHHHHHHSSGLVPRGSHMA at
the N-terminus compared to the published sequence. Additionally, at
position 2 in the amino acid sequence, a leucine residue has been
replaced by an alanine. iPGM expressed with a native N-terminal
sequence had very similar kinetic constants (data not shown).
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2.2. Over-expression and puri¢cation of phosphoglycerate mutase
enzymes
For both proteins, cells were grown in LB medium containing 100
Wg/ml carbenicillin in shaker £asks at 28‡C to an A600 of 0.8. IPTG
was added to a ¢nal concentration of 0.1 mM, and the cells were
incubated for an additional 2.5 h under the same growth conditions.
Cells were harvested by centrifugation, subjected to one freeze-thaw
cycle to aid lysis, and resuspended in 5 ml per g (wet weight of cells)
of lysis bu¡er (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 0.2 mM
DTT). Cells were lysed by sonication (three 45 s bursts on ice), and
the lysate was cleared by centrifugation (4‡C; 20 min; 40 000Ug). The
cleared lysate was subjected to ammonium sulphate fractionation.
2.2.1. dPGM. The protein precipitating between 50% and 85%
ammonium sulphate saturation was resuspended in bu¡er F (20 mM
Tris-HCl, pH 7.5, 300 mM KCl), and applied to a Superdex 200 26/70
size exclusion column (Amersham Pharmacia) equilibrated with bu¡er
F, with a £ow rate of 2.5 ml/min. dPGM eluted with an apparent
molecular mass of 49 kDa, suggesting that the protein is a dimer of
28 kDa subunits. Fractions containing dPGM were pooled and
dialysed against bu¡er A (20 mM Tris-HCl pH 8.5) at 4‡C overnight.
The dialysed protein was next applied to a POROS HQ 20/100 cation
exchange column (Perseptive Biosystems) pre-equilibrated with bu¡er
A, and eluted with a gradient of 0^0.2 M KCl in bu¡er A. Fractions
collected from the column were analysed by SDS-PAGE, and those
containing essentially pure dPGM were pooled and concentrated.
2.2.2. iPGM. The protein precipitating between 25% and 50%
ammonium sulphate saturation was resuspended in bu¡er MC
(20 mM NaPO4, pH 7.5, 0.5 M KCl), and applied to a 5 ml HiTrap
metal chelating column (Amersham-Pharmacia) pre-loaded with nick-
el chloride. The column was washed with three column volumes of
bu¡er MC+50 mM imidazole to release weakly bound proteins, fol-
lowed by three volumes of bu¡er MC+250 mM imidazole to elute
iPGM. The protein was further puri¢ed by size exclusion chromatog-
raphy as described for the dPGM enzyme. iPGM eluted with an
apparent molecular mass of 61 kDa, consistent with the calculated
molecular mass of the monomeric protein of 56 kDa.
2.3. Estimation of protein concentrations
Protein concentrations were estimated both by computer predic-
tions of extinction coe⁄cients at 280 nm (O0:1%280nm = 1.9 for dPGM
and 0.65 for iPGM), and by dye binding assay using bovine serum
albumin as a standard [12]. These techniques were in agreement to
within 10%.
2.4. Enzyme assays
Phosphoglycerate mutase activities in the 3-PGA to 2-PGA (for-
ward) and 2-PGA to 3-PGA (reverse) directions were monitored at
30‡C using assays coupled to the oxidation of NADH [6]. For the
forward direction, the assay mixture comprised 30 mM Tris-HCl pH
7.0, 20 mM KCl, 5 mM MgSO4, 1 mM ATP, 0.15 mM NADH, 3-
PGA (concentration varied), 0.1 mM 2,3-BPGA (for assay of dPGM
activity), 0.08 U enolase (Roche), 0.5 U pyruvate kinase (Sigma),
0.5 U lactate dehydrogenase (Sigma).
For the reverse direction, the assay mixture comprised 30 mM Tris-
HCl pH 7.0, 20 mM KCl, 5 mM MgSO4, 0.2 mM ADP, 0.15 mM
NADH, 2-PGA (concentration varied), 0.1 mM 2,3-BPGA (for assay
of dPGM activity), 0.5 U phosphoglycerate kinase (Sigma), 0.5 U
glyceraldehyde 3-phosphate dehydrogenase (Roche).
2.5. Vanadate inhibition
Vanadate inhibition experiments were carried out using the NADH-
linked assay in the forward direction. Sodium metavanadate was
added to the reaction mixture containing the phosphoglycerate mutase
enzyme, and after 10 min the assay was initiated by addition of a
saturating concentration of substrate 3-PGA (5 mM). Enzyme activity
was assayed as described above, with triplicate measurements for each
concentration of vanadate used.
2.6. Investigation of mutase expression and activity levels in E. coli
In order to measure the levels of phosphoglycerate mutase activity
in E. coli extracts, an overnight culture of E. coli was used to inocu-
late 100 ml SOB medium, to an initial OD600 of approximately 0.03.
Cells were grown at 37‡C with vigorous shaking. Cell growth was
monitored by measuring the optical density of the culture at 600 nm,
with appropriate dilutions to ensure linearity. At intervals, an aliquot
of cells was removed from the culture, cells were pelleted by centrifu-
gation and resuspended in 60 Wl chilled bu¡er (30 mM Tris-HCl pH
7.0, 20 mM KCl, 5 mM MgSO4). Cells were lysed by sonication, and
cell debris was pelleted by centrifugation at top speed in a microcen-
trifuge for 2 min. The supernatant, containing the soluble protein
fraction, was used to measure dPGM and iPGM activity, and total
protein concentration. Activity and protein assays were carried out in
triplicate, and standard errors did not exceed 10%.
2.7. Electron paramagnetic resonance
EPR spectra were recorded on a Bruker 200D spectrometer (Bruker
UK Ltd., Coventry, UK) ¢tted with an Oxford Instruments ER900
liquid helium cooled £ow cryostat (Oxford Instrument Company Ltd.,
Osney Mead, Oxford, UK). Instrument settings are given in the ¢gure
legend.
3. Results
3.1. Expression and puri¢cation
Both of the phosphoglycerate mutase enzymes were ex-
pressed to a very high level in E. coli under the control of
the T7 RNA polymerase promoter. dPGM was puri¢ed by
size exclusion and anion exchange chromatography, whilst
iPGM was puri¢ed by immobilised metal a⁄nity chromatog-
raphy, followed by size exclusion chromatography (Fig. 2). By
calibrating the size exclusion column with a range of proteins
of known molecular mass, the apparent molecular mass of
dPGM was estimated at 49 kDa, corresponding to a dimer
of 27 kDa subunits. iPGM eluted with an apparent molecular
mass of 61 kDa, suggesting the 56 kDa protein is a monomer
in solution.
3.2. Investigation of iPGM by EPR
As there has been some controversy over the presence of
metal ions in cofactor-independent mutases, we used EPR
spectroscopy to look for the presence of manganese in the
E. coli iPGM protein. As can be seen in Fig. 3, the character-
istic hyper¢ne peaks of manganese were observed, and the
broadening of the peaks relative to the spectrum for free
manganese suggested that the manganese was integrally
Fig. 1. Distribution of cofactor-dependent and -independent phos-
phoglycerate mutases. The E. coli dPGM and iPGM protein sequen-
ces were used to search the SwissProt database. Organisms with
completed genome sequences were placed in one of three categories,
according to the identi¢cation of sequence matches of high signi¢-
cance (P6 1036) : only dPGM present; only iPGM present; both
dPGM and iPGM present. Although no complete genome sequences
are available for vertebrates or higher plants, there is good bio-
chemical evidence that the former possess only dPGM and the latter
iPGM, and they have been classi¢ed accordingly. The archaeal ho-
mologue of iPGM has been identi¢ed based on weak sequence simi-
larity, and has not yet been con¢rmed biochemically [15].
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bound by the protein. These results therefore con¢rm the
presence of manganese in E. coli iPGM.
3.3. Determination of kinetic constants
Steady-state kinetic analyses of the two puri¢ed enzymes
were carried out for the forward (glycolytic) and reverse (glu-
coneogenic) reactions catalysed by phosphoglycerate mutases,
as described in Section 2. Both enzymes displayed Michaelis-
Menten kinetics, and the kinetic constants obtained are sum-
marised in Table 1. The values obtained previously for dPGM
from S. cerevisiae under the same assay conditions are in-
cluded to allow comparison. For both E. coli enzymes, Km
values for the substrates 2-PGA and 3-PGA were in the range
100^200 WM. This di¡ered from the S. cerevisiae enzyme,
which had a 10-fold higher Km for 3-PGA compared to 2-
PGA. The catalytic constants for dPGM are similar for the
forward and reverse reactions, and were approximately 10-
fold higher than those for iPGM. dPGM therefore appears
to be the more active enzyme in both the glycolytic and glu-
coneogenic reactions, but of course total mutase activity in
vivo is dependent on the relative expression levels of the
two enzymes.
3.4. Vanadate inhibition
Vanadate is known to be a potent inhibitor of a number of
cofactor-dependent phosphoglycerate mutases in the micro-
molar range, but does not inhibit cofactor-independent en-
zymes [13]. We tested the e¡ect of vanadate on the activity
of puri¢ed E. coli dPGM and iPGM. Under saturating sub-
strate concentrations (5 mM 3-PGA), iPGM was found to be
insensitive to vanadate at concentrations up to 100 WM,
whereas dPGM was strongly inhibited. By ¢tting the data
for dPGM inhibition with an equation for reversible, compet-
itive inhibition, an apparent KI of 15 nM was calculated (Fig.
4). Inhibition by vanadate therefore appears to be a diagnostic
test for discrimination between the cofactor-dependent and
-independent phosphoglycerate mutases of E. coli.
3.5. Phosphoglycerate mutase activity during the E. coli growth
cycle
The di¡erential inhibition by vanadate of the two phospho-
glycerate mutase enzymes allowed us to quantify the activity
of each enzyme in E. coli cell lysates, and thus to compare
relative expression and activity levels as a function of cell
growth. Total phosphoglycerate mutase activity was ¢rst
Fig. 2. SDS-PAGE analysis of protein expression and puri¢cation.
Lane 1, size markers; lane 2, total soluble protein for cells express-
ing dPGM; lane 3, puri¢ed dPGM; lane 4, total soluble protein for
cells expressing iPGM; lane 5, puri¢ed iPGM.
Fig. 3. X-band EPR spectra of 100 WM free manganese in solution
(A) and iPGM (B). Experimental conditions: protein concentration
in B, 2 mg/ml; temperature, 30 K; modulation amplitude, 5.2
Gauss; modulation frequency, 100 kHz; microwave frequency 9.42
GHz; microwave power 2.0 mW; receiver gain 2.5e5.
Table 1
Kinetic constants for E. coli dPGM and iPGM and S. cerevisiae PGM
dPGM iPGM S. cerevisiae PGMa
Km 3-PGA (WM) 200 þ 27 210 þ 39 510 þ 60
Km 2-PGA (WM) 190 þ 35 97 þ 14 52 þ 7
kcat forward (s31) 330 þ 11 22 þ 1 380 þ 10
kcat reverse (s31) 220 þ 13 10 þ 0.5 520 þ 25
Forward kcat/Km (M31 s31) 1.6U106 1.0U105 7.4U105
Reverse kcat/Km (M31 s31) 1.1U106 1.0U105 1.0U107
Kinetic constants were ascertained as described in Section 2. All points were measured in triplicate, and values are the mean þ S.D. The kinetic
parameters of the cofactor-dependent mutases were measured at saturating concentrations of the 2,3-BPGA cofactor, and are therefore apparent
kcat and Km values.
aData from [16].
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measured using the NADH-linked forward assay, and the
assay was then repeated in the presence of 10 WM vanadate.
Under the latter conditions only the cofactor-independent en-
zyme was active, allowing calculation of the individual activ-
ities of the two enzymes in the lysate. Total protein concen-
trations in lysates were estimated using the Bradford dye
binding assay, and by using the values obtained for the spe-
ci¢c activities of dPGM and iPGM an estimate of the concen-
trations of the two proteins could be made. Phosphoglycerate
mutase activities were measured at all stages of the growth
cycle for E. coli strain DH5K grown in rich medium contain-
ing glucose (Fig. 5). Data obtained using E. coli strain JM101
were qualitatively similar (data not shown). iPGM was ex-
pressed most strongly in early exponential growth, with levels
falling o¡ as cells reached late log phase and stationary phase.
dPGM was expressed slightly later, with peak expression ob-
served in mid to late log phase. The levels of expression of the
two enzymes each peaked at 20 Wg/mg total protein, showing
that both are abundant enzymes in the cell. As the cofactor-
dependent enzyme has a much higher speci¢c activity, the
di¡erential temporal expression of the two enzymes resulted
in a wide variation in the ratio of dPGM to iPGM activity,
ranging from 5-fold to 35-fold higher during cell growth.
4. Discussion
It has long been appreciated that cofactor-dependent and
-independent phosphoglycerate mutases have a complex dis-
tribution in nature [14]. Whilst it was established that verte-
brates possessed the former and higher plants the latter, the
distribution in bacteria and fungi was known to be compli-
cated to the point of appearing haphazard. The advent of
whole-genome sequencing projects has provided us with a
wealth of unequivocal information on the occurrence of the
two enzymes (Fig. 1), and has highlighted the unexpected
¢nding that some bacteria encode both proteins. Although
the cofactor-independent mutase is a potential drug target in
many organisms of biomedical relevance, it remains perhaps
the least characterised of all the glycolytic enzymes, with fun-
damental questions regarding its structure and mechanism
unresolved. One example of this is the controversy over the
presence and importance of metal ions in iPGMs. Puri¢cation
of milligram quantities of E. coli iPGM allowed us to dem-
onstrate the presence of bound manganese directly using EPR.
Given this ¢nding, and the conservation of metal binding
Fig. 4. Inhibition of dPGM by vanadate. Vanadate inhibition of
dPGM was measured using the forward NADH-linked assay under
saturating substrate concentrations (5 mM 3-PGA). Increasing con-
centrations of vanadate were added to dPGM in the reaction mix-
ture and incubated for 10 min prior to initiation of the assay by ad-
dition of the substrate 3-PGA. All data points were measured in
triplicate, and means þ S.D. are shown. Assuming competitive inhib-
ition by vanadate, the KI for the inhibitor can be calculated as
0.015 WM. If non-competitive inhibition is assumed, the KI for va-
nadate is 0.29 WM. Clearly, vanadate is a potent inhibitor of dPGM
at sub-micromolar concentrations.
Fig. 5. dPGM and iPGM expression as a function of E. coli growth
phase. The details of the assay are described in Section 2. A: The
growth of a culture of E. coli strain DH5K was followed by measur-
ing the optical density of suitably diluted aliquots at 600 nm. B:
Utilising the di¡erential inhibition of dPGM and iPGM by vana-
date to distinguish between the two enzymes, activities were meas-
ured during cell growth. PGM activity was measured in triplicate at
saturating substrate concentrations using the forward (glycolytic) as-
say. Standard deviations were found to be below 10% for each
point. The expression levels of iPGM and dPGM were calculated
by dividing the observed activity of the two enzymes by their re-
spective speci¢c activities, yielding the amount of each enzyme
present in the cell lysate. Total protein concentration was de-
termined by a dye binding assay [12] in triplicate (standard
errors 6 10%), and Wg mutase per mg total protein was plotted for
the two enzymes at the six growth stages.
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residues between iPGM and alkaline phosphatase [1], we can
now predict with some con¢dence that all cofactor-independ-
ent mutases are, like the Bacillus iPGMs, metalloenzymes with
bound manganese perhaps ful¢lling a catalytic role.
Comparison of the kinetic properties and expression levels
of the two phosphoglycerate mutases of E. coli has allowed
the metabolic role of each to be assessed. Both catalyse the
interconversion of 2- and 3- phosphoglycerate in the glycolytic
and gluconeogenic directions, but dPGM has at least a 10-fold
higher speci¢c activity for both reactions. The observation
that vanadate is a potent inhibitor speci¢c for dPGM has
allowed us to determine the relative expression and speci¢c
activity levels of the two enzymes in E. coli. Variation in the
expression levels with growth phase was observed, with iPGM
expressed slightly earlier than dPGM. Although both enzymes
are highly expressed in E. coli, the 10-fold higher speci¢c
activity of dPGM ensures that dPGM is the dominant mutase
activity in E. coli.
In addition to identifying the predominance of dPGM, our
results also question the role of iPGM in E. coli. One possi-
bility is that iPGM catalyses an alternative reaction that is
important for E. coli metabolism. Wheat germ iPGM has
previously been shown to act as a phosphatase for a variety
of small compounds including phosphoenolpyruvate, 2-phos-
pholactate and 3-phosphohydroxypropionate [10], and these
or related activities might have biological relevance under
certain growth conditions. Creation of iPGM and dPGM
null mutants in E. coli will allow the role and importance of
both enzymes to be tested in more detail.
Acknowledgements: We thank Simon George for the EPR spectros-
copy, Bill Hunter for the dPGM expression construct, and Nick Price
for helpful discussions. This work was supported by equipment grants
from the Royal Society and Tenovus-Scotland. M.F.W. is a Royal
Society University Research Fellow.
References
[1] Galperin, M.Y., Bairoch, A. and Koonin, E.V. (1998) Protein
Sci. 7, 1829^1835.
[2] Fothergill-Gilmore, L.A. and Watson, H.C. (1989) Adv. Enzy-
mol. Relat. Areas Mol. Biol. 62, 227^313.
[3] Rigden, D.J., Walter, R.A., Phillips, S.E. and Fothergill-Gilmore,
L.A. (1999) J. Mol. Biol. 286, 1507^1517.
[4] Rigden, D.J., Alexeev, D., Phillips, S.E. and Fothergill-Gilmore,
L.A. (1998) J. Mol. Biol. 276, 449^459.
[5] White, M.F. and Fothergill-Gilmore, L.A. (1990) Biochem. Soc.
Trans. 18, 257.
[6] White, M.F. and Fothergill-Gilmore, L.A. (1992) Eur. J. Bio-
chem. 207, 709^714.
[7] Walter, R.A., Nairn, J., Duncan, D., Price, N.C., Kelly, S.M.,
Rigden, D.J. and Fothergill-Gilmore, L.A. (1999) Biochem. J.
337, 89^95.
[8] Nairn, J., Price, N.C., Kelly, S.M., Rigden, D., Fothergill-Gil-
more, L.A. and Krell, T. (1996) Biochim. Biophys. Acta 1296,
69^75.
[9] Grana, X. et al. (1992) J. Biol. Chem. 267, 12797^12803.
[10] Breathnach, R. and Knowles, J.R. (1977) Biochemistry 16, 3054^
3060.
[11] Huang, Y. and Dennis, D.T. (1995) Eur. J. Biochem. 229, 395^
402.
[12] Bradford, M.M. (1976) Anal. Biochem. 72, 248^254.
[13] Carreras, J., Bartrons, R. and Grisolia, S. (1980) Biochem. Bio-
phys. Res. Commun. 96, 1267^1273.
[14] Carreras, J., Mezquita, J., Bosch, J., Bartrons, R. and Pons, G.
(1982) Comp. Biochem. Physiol. [B] 71, 591^597.
[15] Koonin, E.V., Mushegian, A.R., Galperin, M.Y. and Walker,
D.R. (1997) Mol. Microbiol. 25, 619^637.
[16] White, M.F. (1989) PhD Thesis, Department of Biochemistry,
Edinburgh University, Edinburgh.
FEBS 22360 16-7-99
H.I. Fraser et al./FEBS Letters 455 (1999) 344^348348
